Cancer during young adulthood carries long-term mental toll, study finds

Updated on: June 14,2025

Cancer during young adulthood carries long-term mental toll, study finds

Updated on:June 14,2025

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on: March 22,2024

Addition of durvalumab, bevacizumab to TACE beneficial in liver cancer

by Elana GotkineFor patients with embolization-eligible unresectable hepatocellular carcinoma (uHCC), the addition of durvalumab (D) and bevacizumab (B) to transarterial chemoembolization (TACE) impro

Updated on:March 22,2024

Cancer patients benefit from therapy that changes negative thoughts, behavior

Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.However, when they identify and “talk back” to these unhelpful thoughts through cognitive behavioral therapy, their mental health and quality of life s

Updated on: September 14,2024

Cancer patients benefit from therapy that changes negative thoughts, behavior

Many cancer patients struggle with their conditions by having negative thoughts, behaviors and emotions.However, when they identify and “talk back” to these unhelpful thoughts through cognitive behavioral therapy, their mental health and quality of life s

Updated on:September 14,2024

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

Updated on: December 28,2023

U.S. cancer deaths decline overall, but prostate cancers make rebound

by Dennis ThompsonCancer deaths continue to decline, dropping 33% since 1991 and saving an estimated 3.8 million lives, according to the American Cancer Society's annual statistics report.But indi

Updated on:December 28,2023

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Updated on: March 01,2024

Researchers: Favorable survival, fewer side effects after reduced therapy for HPV-linked head and neck cancer

by University of North Carolina at Chapel Hill School of MedicineBhisham Chera, MD. Credit: University of North Carolina at Chapel Hill School of MedicineUniversity of North Carolina Lineberger C

Updated on:March 01,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on: May 07,2024

Evaluation of ruxolitinib, a JAK inhibitor, in multiple myeloma

by Impact Journals LLCRuxolitinib exerts its anti-myeloma effects through several mechanisms. Credit:Oncotarget(2024). DOI: 10.18632/oncotarget.28547A new research perspective titled &quot

Updated on:May 07,2024

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on: January 10,2024

Delivering oxygen to tumors may be key in overcoming radiation therapy resistance

by National Institute of Biomedical Imaging and BioengineeringOxygen in tumors is necessary for radiotherapy to effectively treat cancer, but when tumors are hypoxic, this method can fail. A new strat

Updated on:January 10,2024

Colon cancer screenings are more effective than previously understood: Study

by Peter Dizikes,Massachusetts Institute of TechnologyCredit: Unsplash/CC0 Public DomainScreening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized

Updated on: December 30,2023

Colon cancer screenings are more effective than previously understood: Study

by Peter Dizikes,Massachusetts Institute of TechnologyCredit: Unsplash/CC0 Public DomainScreening for colon cancer reduces cancer rates by substantially more than previous analyses of randomized

Updated on:December 30,2023

Researchers testing new brain cancer vaccine

by Rush University Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Rush University Medical Center is part of a new clinical trial testing whether an experimental vacci

Updated on: June 01,2024

Researchers testing new brain cancer vaccine

by Rush University Medical CenterGlioblastoma (histology slide). Credit: Wikipedia/CC BY-SA 3.0Rush University Medical Center is part of a new clinical trial testing whether an experimental vacci

Updated on:June 01,2024

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on: May 06,2024

Treating Alzheimer's, Parkinson's, type 2 diabetes by eliminating protein aggregation in brain, pancreas

by Steve Martin,Purdue UniversityCredit: Wikimedia CommonsPurdue University researchers have taken the first steps to treat Alzheimer's disease, Parkinson's disease and Type 2 diabetes b

Updated on:May 06,2024

Novel blood test helps improve cancer treatments

by Kurt Bodenmüller,University of ZurichStudy scheme depicting the plasma sample collection schedule in the different patient groups. Credit:Radiotherapy and Oncology(2024). DOI: 10.

Updated on: July 08,2024

Novel blood test helps improve cancer treatments

by Kurt Bodenmüller,University of ZurichStudy scheme depicting the plasma sample collection schedule in the different patient groups. Credit:Radiotherapy and Oncology(2024). DOI: 10.

Updated on:July 08,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on: January 08,2024

Combination cancer therapies can shrink tumors and improve outcome in advanced non-small lung cancer: Clinical trial

byYale UniversityCredit: Pixabay/CC0 Public DomainWhile pembrolizumab is an approved treatment for patients with stage III non-small cell lung cancer (NSCLC), only some patients respond to this

Updated on:January 08,2024